sivextro- tedizolid phosphate tablet, film coated sivextro- tedizolid phosphate injection, powder, lyophilized, for solution
merck sharp & dohme llc - tedizolid phosphate (unii: o7drj6r4dw) (tedizolid - unii:97hlq82ngl) - tedizolid phosphate 200 mg - sivextro® is an oxazolidinone-class antibacterial indicated in adult and pediatric patients 12 years of age and older for the treatment of acute bacterial skin and skin structure infections (absssi) caused by susceptible isolates of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), streptococcus pyogenes , streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), and enterococcus faecalis . to reduce the development of drug-resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs, sivextro should be used only to treat absssi that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemio
sivextro
merck sharp & dohme b.v. - tedizolid phosphate - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
sivextro tablet
merck canada inc - tedizolid phosphate - tablet - 200mg - tedizolid phosphate 200mg - oxazolidinones
sivextro powder for solution
merck canada inc - tedizolid phosphate - powder for solution - 200mg - tedizolid phosphate 200mg - oxazolidinones
sivextro- tedizolid phosphate tablet, film coated sivextro- tedizolid phosphate injection, powder, lyophilized, for solution
nabriva therapeutics us, inc. - tedizolid phosphate (unii: o7drj6r4dw) (tedizolid - unii:97hlq82ngl) - sivextro® is an oxazolidinone-class antibacterial indicated in adult and pediatric patients 12 years of age and older for the treatment of acute bacterial skin and skin structure infections (absssi) caused by susceptible isolates of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), streptococcus pyogenes , streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), and enterococcus faecalis . to reduce the development of drug-resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs, sivextro should be used only to treat absssi that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemio
sivextro 200mg powder for concentrate for solution for infusion vials
merck sharp & dohme ltd - tedizolid phosphate - powder for solution for infusion - 200mg
sivextro 200mg tablets
merck sharp & dohme ltd - tedizolid phosphate - tablet - 200mg
sivextro film-coated tablet 200mg
merck sharp & dohme (malaysia) sdn bhd - tedizolid phosphate -
sivextro lyophilized powder for solution for infusion 200mg per vial
merck sharp & dohme (malaysia) sdn bhd - tedizolid phosphate -
sivextro film-coated tablet 200mg
msd pharma (singapore) pte. ltd. - tedizolid 165mg eqv tedizolid phosphate - tablet, film coated - tedizolid 165mg eqv tedizolid phosphate 200mg